Mon, Sep 14, 2026 - Page 7
4906 indexed SquawkNews stories from this UTC day. Showing 721-840.
L
Diamondback Energy Director Sold Shares Worth Over $15M
Travis D. Stice, a Director, reported a direct sale of Common Stock at a weighted average price of $204.3103 per share. The total sale amounted to $15,323,272. Following the transaction, Stice directly owns 49,727 shares
EQUITY | Sep 14, 2026, 08:11 PM UTC
L
ExpreS2ion Biotech Holding AB (publ) (OMXSTO:EXPRS2) Seeks Broad Share Issue Authorization at Oct 1 EGM
ExpreS2ion will hold an Oct 1 EGM to seek authorization for the board to issue shares, convertibles and/or warrants, with or without pre-emptive rights, for cash, in-kind or set-off, within articles-of-association limits
EQUITY | Sep 14, 2026, 08:11 PM UTC
H
CTO Realty Growth Acquires Zona Rosa, 768K Square Foot Mixed-Use Center In Kansas City, Missouri, For $63.3M Or $82 Per Square Foot
Acquired Significantly Below Replacement Cost - - Property Provides Long-Term Repositioning Opportunity - - 2026 Year-to-Date Investments Total $334 Million - WINTER PARK, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) -- CTO Rea
LIVE | Sep 14, 2026, 08:11 PM UTC
L
M.O.B.A. Network AB (publ) Plans SEK 11.3M Directed Share Issue to Meet Bond Terms
M.O.B.A. Network AB (publ) proposes a directed issue of up to 11,915,962 shares at SEK 0.95 to raise up to SEK 11.3M, partly via bond set-off, to secure its remaining amortization obligation under its bonds.Material Deta
EQUITY | Sep 14, 2026, 08:10 PM UTC
L
ABAT: Record 407% revenue growth and positive adjusted gross profit achieved, with major project advances
Record revenue growth of 407% to $21.7 million and first-ever positive adjusted gross profit marked a transformational year, with strengthened balance sheet, major federal grants, and significant progress in recycling an
NEWS | Sep 14, 2026, 08:10 PM UTC
L
NVCR: Growth in oncology franchises, global expansion, and profitability targets drive future outlook
Management outlined renewed growth in GBM, strategic launches in pancreatic and lung cancer, and disciplined cost controls. Global expansion is underway, with strong progress in Europe and Japan, and profitability is tar
NEWS | Sep 14, 2026, 08:10 PM UTC
H
Enova Withdraws Bank Regulatory Applications
Company Reaffirms 2026 Guidance and Intends to Accelerate Share RepurchasesCHICAGO, Sept. 14, 2026 // -- Enova International (NYSE:ENVA), a leading financial services company powered by machine learning and world-class a
NEWS | Sep 14, 2026, 08:10 PM UTC
L
Notice to attend an Extraordinary General Meeting in ExpreS2ion Biotech Holding AB (publ)
Helsingborg, Sweden, 14 September 2026 - The shareholders of ExpreS2ion Biotech Holding AB (publ), reg. no. 559033-3729 (the "Company"), are hereby invited to attend an extraordinary general meeting on 1 October 2026 at
NEWS | Sep 14, 2026, 08:10 PM UTC
L
CHWY: Health services, AI, and disciplined investment drive growth and margin expansion
The discussion highlighted strong growth in health services, robust customer retention, and expanding AI initiatives. Focus remains on U.S. health verticals, with international expansion deprioritized. Financial discipli
NEWS | Sep 14, 2026, 08:10 PM UTC
L
Kallelse till extra bolagsstämma i ExpreS2ion Biotech Holding AB (publ)
Helsingborg, Sweden, 14 September 2026 - Aktieägarna i ExpreS2ion Biotech Holding AB (publ), org.nr 559033-3729 ("Bolaget"), kallas härmed till extra bolagsstämma den 1 oktober 2026 klockan 10:00 på Mindpark, Rönnowsgata
NEWS | Sep 14, 2026, 08:10 PM UTC
L
Boot Barn Holdings, Inc. Announces September Conference Schedule
Boot Barn Holdings, Inc. (NYSE: BOOT) (the “Company,” “we,” “us,” and “our””) today announced participation in the following investor conferences:John Hazen, Chief Executive Officer, commented, “We are pleased with the p
NEWS | Sep 14, 2026, 08:10 PM UTC
H
Veracyte Contemplated Oper Expenses of Convergent in 2026 Adj EBITDA Guidance and Isn't Updating at This Time >VCYT
Veracyte Contemplated Oper Expenses of Convergent in 2026 Adj EBITDA Guidance and Isn't Updating at This Time >VCYT
EARNINGS | Sep 14, 2026, 08:10 PM UTC
L
Proposal for an up to SEK 11.3 million directed share issue in M.O.B.A. to secure obligations under its outstanding bonds
The Board of Directors of M.O.B.A. Network AB (publ) (the “Company”) has received a proposal regarding a new issue of maximum 11,915,962 shares with deviation from the shareholders’ preferential rights (the “Directed Iss
EQUITY | Sep 14, 2026, 08:10 PM UTC
L
First Trust Announces Approval of Liquidation of the First Trust Horizon Managed Volatility Developed International ETF
First Trust Advisors L.P. (“FTA”) announced today approval of the liquidation of the First Trust Horizon Managed Volatility Developed International ETF (Nasdaq: HDMV), a series of First Trust Exchange-Traded Fund III (th
NEWS | Sep 14, 2026, 08:10 PM UTC
L
First Trust Announces Approval of Liquidation of the First Trust Horizon Managed Volatility Small/Mid ETF
First Trust Advisors L.P. (“FTA”) announced today approval of the liquidation of the First Trust Horizon Managed Volatility Small/Mid ETF (Nasdaq: HSMV), a series of First Trust Exchange-Traded Fund III (the “Fund”).Base
NEWS | Sep 14, 2026, 08:10 PM UTC
L
PECO: Retail REITs target 9—10% annual returns through stable cash flows, growth, and disciplined investment
Retail REITs are capitalizing on strong supply-demand fundamentals, high occupancy, and resilient tenant demand, with strategies focused on internal growth, selective acquisitions, and disciplined capital allocation. Pro
NEWS | Sep 14, 2026, 08:10 PM UTC
H
Goldman Sachs Stock Slips Monday: What's Going On?
Shares of The Goldman Sachs Group Inc (NYSE: GS ) are trading lower Monday afternoon following cautionary commentary from Bank of America CEO Brian Moynihan regarding third-quarter dealmaking and trading activity trigger
LIVE | Sep 14, 2026, 08:10 PM UTC
L
ORC - Orchid Island Capital Announces September 2026 Monthly Dividend and August 31, 2026 RMBS Portfolio Characteristics
ORC - Orchid Island Capital Announces September 2026 Monthly Dividend and August 31, 2026 RMBS Portfolio Characteristics
NEWS | Sep 14, 2026, 08:10 PM UTC
L
Nasdaq Composite Falls 146.62 Points (0.56%)
Nasdaq Composite Falls 146.62 Points (0.56%)
NEWS | Sep 14, 2026, 08:10 PM UTC
L
S&P 500 Falls 37.00 Points (0.48%)
S&P 500 Falls 37.00 Points (0.48%)
NEWS | Sep 14, 2026, 08:10 PM UTC
L
DJIA Falls 152.09 Points (0.29%)
DJIA Falls 152.09 Points (0.29%)
NEWS | Sep 14, 2026, 08:10 PM UTC
L
Rimini Street to Offer Support Services to Datacom Customers Under New Agreement
By Elias SchisgallRimini Street's support services will be offered by Datacom to public and private sector customers in Australia and New Zealand under a new partnership between the two companies.Rimini, which describes
NEWS | Sep 14, 2026, 08:09 PM UTC
L
LSCC - Lattice to Showcase Next Gen Automotive Sensing Innovations at AutoSens Europe 2026
LSCC - Lattice to Showcase Next Gen Automotive Sensing Innovations at AutoSens Europe 2026
NEWS | Sep 14, 2026, 08:09 PM UTC
L
Radiant Logistics, Inc. Q4 Rev $261.4M, EPS $0.15; Extends $200M Credit Facility
Radiant Logistics reported Q4 FY26 revenue of $261.4M and diluted EPS of $0.15, with adjusted EBITDA of $10.4M. It extended its $200M revolver to 2031 and ended Q4 with no net debt.Material DetailsContext by AI AnalystTh
EARNINGS | Sep 14, 2026, 08:09 PM UTC
L
RLGT - RADIANT LOGISTICS ANNOUNCES RESULTS FOR THE FOURTH FISCAL QUARTER AND YEAR ENDED JUNE 30, 2026
RLGT - RADIANT LOGISTICS ANNOUNCES RESULTS FOR THE FOURTH FISCAL QUARTER AND YEAR ENDED JUNE 30, 2026
NEWS | Sep 14, 2026, 08:09 PM UTC
L
ExpreS2ion Biotech Holding AB Secures SEK 19.3M TO 13 Guarantee, Adds SEK 50M Put Option
ExpreS2ion obtained a ~SEK 19.3M guarantee for its TO 13 warrants and entered a put option deal with Alumni Capital for up to SEK 50M, subject to EGM approval. TO 13 exercise price is SEK 1.60; the put option has a SEK 4
NEWS | Sep 14, 2026, 08:09 PM UTC
L
BRIEF-Radiant Logistics Q4 Revenue USD 261.4 Million
Sep 14 (Reuters) - Radiant Logistics Q4 gross profit USD 64.4 million.
EARNINGS | Sep 14, 2026, 08:09 PM UTC
L
RADIANT LOGISTICS ANNOUNCES RESULTS FOR THE FOURTH FISCAL QUARTER AND YEAR ENDED JUNE 30, 2026
Fourth-quarter growth accelerates across revenue, profitability and margin; Company positioned for future growth with extended and enhanced $200 million credit facility, and no net debt.RENTON, Wash., Sept. 14, 2026 // -
EARNINGS | Sep 14, 2026, 08:08 PM UTC
L
Designer Brands Price Target Raised to $6.50/Share From $6.00 by UBS
Ratings actions from Benzinga
NEWS | Sep 14, 2026, 08:08 PM UTC
L
KAPA: ENV105 leads a robust pipeline targeting cancer resistance, with strong early clinical results and funding
Focused on overcoming cancer drug resistance and immune suppression, the company advances a pipeline led by ENV105, now in Phase 2 for prostate cancer and Phase 1 for lung cancer. Early clinical data show promising effic
NEWS | Sep 14, 2026, 08:08 PM UTC
L
Hemlo Mining: Temporary Electrical Bypass System Established
Hemlo Mining: Temporary Electrical Bypass System Established
NEWS | Sep 14, 2026, 08:07 PM UTC
L
HITI: Record revenue, net income, and cash flow highlight robust growth and expanding market share
Record Q3 2026 results with revenue up 33% year-over-year, record net income, and strong free cash flow. Canna Cabana expanded market share and loyalty memberships, while Remexian posted record sales in Germany. Outlook
EARNINGS | Sep 14, 2026, 08:07 PM UTC
L
Takeda Pharmaceutical Company: Upcoming launches and data readouts signal a major inflection point for growth and innovation
Leadership transition is underway with a new CEO set to unveil strategy at December's Capital Markets Day. Key launches include ORZEYFUL for narcolepsy and zasocitinib for psoriasis and IBD, with robust clinical data and
NEWS | Sep 14, 2026, 08:07 PM UTC
L
Hemlo Mining: No Injuries Associated With Outage
Hemlo Mining: No Injuries Associated With Outage
NEWS | Sep 14, 2026, 08:07 PM UTC
L
HAIN CELESTIAL GROUP INC FY 2026: Revenue $1.35B, EPS $(3.36) — 10-K Summary
HAIN CELESTIAL GROUP INC reported fiscal 2026 revenue of $1.35B and a net loss of $304.9M, with diluted loss per share of $(3.36), reflecting a year-over-year revenue decline driven largely by divestitures and improved r
EARNINGS | Sep 14, 2026, 08:07 PM UTC
H
Veracyte Acquires Convergent Genomics In $150M Deal, With Up To $30M Milestone Payments
Veracyte, Inc. (NASDAQ: VCYT ), a leading cancer diagnostics company, today announced its acquisition of Convergent Genomics. The acquisition adds Convergent Genomics’ UroAmp platform, including its proprietary urinary t
LIVE | Sep 14, 2026, 08:07 PM UTC
L
Ellington Financial Announces Upsizing and Pricing of Additional 7.375% Senior Unsecured Notes Due 2030
Ellington Financial Inc. (NYSE: EFC) (the “Company”) today announced the pricing of its previously announced offering, which was upsized from $100 million to $150 million in aggregate principal amount, of 7.375% senior u
NEWS | Sep 14, 2026, 08:07 PM UTC
L
Callaway Golf Is Maintained at Neutral by UBS
Ratings actions from Benzinga
NEWS | Sep 14, 2026, 08:07 PM UTC
L
BNTC: BB-301 clinical progress and robust cash reserves highlight a year of operational and financial momentum
BB-301 clinical development advanced with full enrollment of Cohort 2 and positive interim results, while a strong cash position of $180 million supports ongoing operations. Net loss widened to $45.5 million as R&D and G
EARNINGS | Sep 14, 2026, 08:06 PM UTC
H
KMTS: Revenue up 60% year-over-year, gross margin at 56.5%, FY27 guidance raised to $141M
Revenue surged 60% year-over-year to $31.0 million with gross margin expanding to 56.5%. Net loss widened to $44.1 million, while FY27 revenue guidance was raised to $141 million, reflecting 48% projected growth.Original
EARNINGS | Sep 14, 2026, 08:06 PM UTC
L
Hemlo Mining: Substation Had Temporary Electrical Outage on Sept. 4
Hemlo Mining: Substation Had Temporary Electrical Outage on Sept. 4
NEWS | Sep 14, 2026, 08:06 PM UTC
L
BAC: Strong consumer spending, disciplined risk management, and AI-driven innovation support growth
Consumer spending and credit quality remain strong, supporting solid loan and deposit growth. AI and infrastructure investments are driving efficiency and innovation, while capital and risk management remain disciplined.
NEWS | Sep 14, 2026, 08:06 PM UTC
L
Veracyte: Acquisition Includes $150 M in Upfront Cash and Up to $30 M in Additional Cash Tied to Key Milestones >VCYT
Veracyte: Acquisition Includes $150 M in Upfront Cash and Up to $30 M in Additional Cash Tied to Key Milestones >VCYT
MNA | Sep 14, 2026, 08:06 PM UTC
H
PBYI: Strong revenue growth and promising clinical progress with biomarker-driven cancer therapies
NERLYNX continues to show strong revenue growth and expanded guidance, while alisertib advances in phase II trials for breast and lung cancer with promising biomarker-driven results. Additional interim data and a focus o
EARNINGS | Sep 14, 2026, 08:06 PM UTC
L
YARW Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
YARW Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
EQUITY | Sep 14, 2026, 08:06 PM UTC
M
CBOT corn ends firm, following soybeans and crude oil
Chicago Board of Trade corn futures ended modestly higher on Monday, supported by strength in soybeans CBOT:ZS1! and crude oil NYMEX:CL1! futures, traders said.
COMMODITIES | Sep 14, 2026, 08:06 PM UTC
L
Hemlo Mining Corp. Reports Underground Electrical Substation Outage; Mine-Wide Ops Continue
Hemlo Mining Corp. Reports Underground Electrical Substation Outage; Mine-Wide Ops Continue
NEWS | Sep 14, 2026, 08:06 PM UTC
L
Dave & Buster's: 2Q Comparable Store Sales Decreased 2.9% Compared to the Same Calendar Period in FY25 >PLAY
Dave & Buster's: 2Q Comparable Store Sales Decreased 2.9% Compared to the Same Calendar Period in FY25 >PLAY
EARNINGS | Sep 14, 2026, 08:06 PM UTC
H
RNXT: RenovoCath's commercial and clinical momentum accelerates with strong survival data and expanding adoption
RenovoCath's targeted drug delivery system is gaining rapid commercial traction, now in 21 centers with plans to exceed 35 by year-end. Interim phase III data show a six-month survival benefit and 65% reduction in toxici
EARNINGS | Sep 14, 2026, 08:06 PM UTC
L
VCYT - Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform
VCYT - Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform
NEWS | Sep 14, 2026, 08:05 PM UTC
L
APWC - Asia Pacific Wire & Cable Corporation Limited Announces Results of 2026 Annual General Meeting and Corporate Updates
APWC - Asia Pacific Wire & Cable Corporation Limited Announces Results of 2026 Annual General Meeting and Corporate Updates
NEWS | Sep 14, 2026, 08:05 PM UTC
L
RVMD - Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
RVMD - Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
REGULATION | Sep 14, 2026, 08:05 PM UTC
L
CPHC - Canterbury Park Holding Corporation Announces Quarterly Cash Dividend
CPHC - Canterbury Park Holding Corporation Announces Quarterly Cash Dividend
NEWS | Sep 14, 2026, 08:05 PM UTC
L
ACIC - American Coastal Insurance Corporation Announces Restructured Exclusive Managing Agency Agreement with AmRisc, LLC
ACIC - American Coastal Insurance Corporation Announces Restructured Exclusive Managing Agency Agreement with AmRisc, LLC
NEWS | Sep 14, 2026, 08:05 PM UTC
L
CTO Realty Growth Expands Into Kansas City Market With Acquisition Of Zona Rosa For $63.3 Million >CTO
CTO Realty Growth Expands Into Kansas City Market With Acquisition Of Zona Rosa For $63.3 Million >CTO
MNA | Sep 14, 2026, 08:05 PM UTC
L
HAIN: Significant sales decline, major divestitures, and going concern risk amid debt and restructuring
Net sales declined 13.2% to $1.35 billion in fiscal 2026, with a net loss of $304.9 million and Adjusted EBITDA down 21.8%. Major divestitures and restructuring actions were undertaken, and substantial doubt exists about
EARNINGS | Sep 14, 2026, 08:05 PM UTC
L
PLAY - Dave & Buster’s Reports Second Quarter 2026 Financial Results
PLAY - Dave & Buster’s Reports Second Quarter 2026 Financial Results
EARNINGS | Sep 14, 2026, 08:05 PM UTC
L
Quantum Appoints Mike Heuer as Chief Information Officer
Quantum Corporation (Nasdaq: QMCO) today announced the appointment of Mike Heuer as its Chief Information Officer, effective immediately. Heuer will lead Quantum’s global information technology organization, including en
NEWS | Sep 14, 2026, 08:05 PM UTC
L
Saudi Arabia may be just days away from not being able to export much oil
By Claudia AssisThe oil-exporting kingdom is now dealing with the shutdown of its East-West pipeline. Energy prices 'are only going to rise on the back of this.'Satellite image showing fire damage and extensive blackened
COMMODITIES | Sep 14, 2026, 08:05 PM UTC
L
PETS - PetMeds Appoints Andrew Parry as Chief Technology Officer
PETS - PetMeds Appoints Andrew Parry as Chief Technology Officer
NEWS | Sep 14, 2026, 08:05 PM UTC
L
AXSM: AUVELITY's growth accelerates in new indications, with strong pipeline and financial outlook
China-originated innovation and AI are shaping R&D and commercial operations, while AUVELITY's launch shows strong growth, especially in the Medicare 65+ segment. Conservative market assumptions support an $8 billion pea
EARNINGS | Sep 14, 2026, 08:05 PM UTC
H
US Stocks Drop on Chipmaker Selloff
US equity indices closed lower on Monday, dragged down by a selloff in chipmakers. The S&P 500 fell 0.5% and the Nasdaq dropped 0.8%, while the Dow shed 152 points. Anthropic CEO Dario Amodei called for a slower pace of
CENTRAL_BANK | Sep 14, 2026, 08:05 PM UTC
L
Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) will be covered in EviCore by Evernorth clinical guidelines effective
NEWS | Sep 14, 2026, 08:05 PM UTC
L
Royal Gold Presenting at the Mining Forum Americas 2026
Royal Gold, Inc. (NASDAQ: RGLD) announced today that management will present at the Mining Forum Americas 2026.Bill Heissenbuttel, President and Chief Executive Officer, will participate in a 20-minute fireside chat on M
COMMODITIES | Sep 14, 2026, 08:05 PM UTC
L
O - Realty Income to Present at Bank of America's 2026 Global Real Estate Conference
O - Realty Income to Present at Bank of America's 2026 Global Real Estate Conference
NEWS | Sep 14, 2026, 08:05 PM UTC
L
NHI - NHI to Participate in the BofA Securities 2026 Global Real Estate Conference; Updates Pipeline
NHI - NHI to Participate in the BofA Securities 2026 Global Real Estate Conference; Updates Pipeline
NEWS | Sep 14, 2026, 08:05 PM UTC
L
Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significan
NEWS | Sep 14, 2026, 08:05 PM UTC
L
Curbline Properties Announces Third Quarter 2026 Investment Update
Curbline Properties Corp. (NYSE: CURB), an owner of convenience centers in suburban, high household income communities, announced today an update on third quarter and full year 2026 investment activity.“The pipeline of o
NEWS | Sep 14, 2026, 08:05 PM UTC
L
Julie K. Streich Joins Apogee Enterprises’ Board of Directors
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading provider of architectural building products and services, as well as high-performance coated materials used in a variety of applications, announced today that its Board
NEWS | Sep 14, 2026, 08:05 PM UTC
L
Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Yarrow Bioscience, Inc. (“Yarrow” or the “Company”) (Nasdaq: YARW), a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, today announced the closing of it
EQUITY | Sep 14, 2026, 08:05 PM UTC
L
BrightSpire Capital Announces $0.16 Per Share Dividend for Third Quarter 2026
BrightSpire Capital, Inc. (NYSE: BRSP) (“BrightSpire Capital” or the “Company”) today announced that the Company’s Board of Directors has declared a dividend of $0.16 per share of Class A common stock for the quarter end
EQUITY | Sep 14, 2026, 08:05 PM UTC
L
Pega Announces Quarterly Cash Dividend for Fourth Quarter of 2026
Pegasystems Inc. (NASDAQ: PEGA), the enterprise AI software company for mission-critical work, today announced a quarterly cash dividend of $0.03 per share, maintaining the company’s current dividend program. The Q4 2026
NEWS | Sep 14, 2026, 08:05 PM UTC
H
ExpreS2ion Obtains Commitment for Warrant Program TO 13 and enters into SEK 50 Million Put Option Agreement with lead investor Alumni Capital
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, RUSSIA, SOUTH
GEOPOLITICS | Sep 14, 2026, 08:05 PM UTC
L
Dave & Buster's 2Q Adj Loss/Shr 27c >PLAY
Dave & Buster's 2Q Adj Loss/Shr 27c >PLAY
NEWS | Sep 14, 2026, 08:05 PM UTC
L
Dave & Buster's 2Q Rev $544.1M >PLAY
Dave & Buster's 2Q Rev $544.1M >PLAY
NEWS | Sep 14, 2026, 08:05 PM UTC
L
Dave & Buster's 2Q Loss/Shr 36c >PLAY
Dave & Buster's 2Q Loss/Shr 36c >PLAY
NEWS | Sep 14, 2026, 08:05 PM UTC
L
Dave & Buster's 2Q Loss $12.5M >PLAY
Dave & Buster's 2Q Loss $12.5M >PLAY
NEWS | Sep 14, 2026, 08:05 PM UTC
L
GLBS - Globus Maritime Limited Announces the Delivery of a 2026-Built Ultramax Dry Bulk Vessel “Glbs Olympia,” Expanding Fleet to Ten Vessels
GLBS - Globus Maritime Limited Announces the Delivery of a 2026-Built Ultramax Dry Bulk Vessel “Glbs Olympia,” Expanding Fleet to Ten Vessels
NEWS | Sep 14, 2026, 08:05 PM UTC
L
AGMB - Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
AGMB - Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
NEWS | Sep 14, 2026, 08:05 PM UTC
H
Zelensky: Ready To Support De-Escalation Following US Proposal
Comments On De-Escalation In X Post - Expects Specifics From Partners - Wants To Ensure Russia Is 'Ready To Stop This War'
GEOPOLITICS | Sep 14, 2026, 08:04 PM UTC
H
Niki BioSolutions presents H.C. Wainwright slides, details merger, product pipeline and near-term revenue sources
Niki BioSolutions disclosed its corporate presentation highlighting the Aptorum—DiamiR all-stock merger completion, validated assays, and near-term pharma services revenue.Key Highlights:Original SEC Filing: Niki BioSolu
MNA | Sep 14, 2026, 08:04 PM UTC
H
Emergent BioSolutions presents transformation update, Q2 results, $40M restructuring savings and revised FY26 guidance
Emergent BioSolutions presented a business update highlighting Q2 momentum in medical countermeasures, a restructuring delivering ~$40M annualized savings and revised FY2026 guidance.Key Highlights:Original SEC Filing: E
EARNINGS | Sep 14, 2026, 08:04 PM UTC
L
Moleculin to present new Annamycin data at AACR and European meetings
Moleculin announced new Annamycin data to be presented at AACR and two European scientific meetings in September 2026.Key Highlights:Original SEC Filing: Moleculin Biotech, Inc. [ MBRX ] - 8-K - Sep. 14, 2026This is an A
REGULATION | Sep 14, 2026, 08:04 PM UTC
L
Yarrow Bioscience Raises About $161.8 Million in Public Stock Offering at $26 Per Share
Yarrow Bioscience entered into an Underwriting Agreement to sell 5,769,231 shares of common stock at $26.00 per share, with underwriters exercising in full a 30-day option for 865,384 additional shares. Net proceeds are
EQUITY | Sep 14, 2026, 08:04 PM UTC
L
Kairos Pharma to Present Investor Update at H.C. Wainwright Conference
Kairos Pharma issued a new investor presentation and will present an update on its clinical program at the H.C. Wainwright conference.Key Highlights:Original SEC Filing: Kairos Pharma, LTD. [ KAPA ] - 8-K - Sep. 14, 2026
REGULATION | Sep 14, 2026, 08:04 PM UTC
L
OpenAI Top Lobbyist Plans Meeting With Lawmakers Today - Politico
OpenAI Top Lobbyist Plans Meeting With Lawmakers Today - Politico
NEWS | Sep 14, 2026, 08:03 PM UTC
L
RFIL: Record sales and margin gains fueled a 267% net income increase, driven by diversified growth
Record quarterly sales and margin expansion drove net income up 267% year-over-year, with strong growth in custom cabling and integrated systems. Diversification into new markets and a shift to higher-value solutions sup
EARNINGS | Sep 14, 2026, 08:03 PM UTC
H
Kestra Medical Techs Prior FY27 Rev Guidance of $137 M >KMTS
Kestra Medical Techs Prior FY27 Rev Guidance of $137 M >KMTS
NEWS | Sep 14, 2026, 08:02 PM UTC
H
Lennar Corporation expected to post earnings of $1.30 a share - Earnings Preview
The company's guidance on June 12 2026 for the period ended August 31 was for gross profit margin of 16%.Previous quarterly performance (using preferred earnings measure in US dollars). This summary was machine generate
EARNINGS | Sep 14, 2026, 08:02 PM UTC
H
Aeluma Inc expected to post a loss of 7 cents a share - Earnings Preview
Previous quarterly performance (using preferred earnings measure in US dollars). This summary was machine generated September 14 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning
EARNINGS | Sep 14, 2026, 08:02 PM UTC
L
EWBC: Growth is driven by strong deposits, wealth management, and technology, supporting top-tier returns
The panel highlighted a U.S.-centric growth strategy fueled by strong deposit inflows, cross-border activity, and a focus on high-income markets. Wealth management and technology investments are driving fee income and op
NEWS | Sep 14, 2026, 08:02 PM UTC
H
Kestra Medical Raised Guidance Represents Growth of 48% Compared to FY26 >KMTS
Kestra Medical Raised Guidance Represents Growth of 48% Compared to FY26 >KMTS
NEWS | Sep 14, 2026, 08:02 PM UTC
L
Kestra Medical Techs Raises FY27 View To Rev $141M >KMTS
Kestra Medical Techs Raises FY27 View To Rev $141M >KMTS
NEWS | Sep 14, 2026, 08:02 PM UTC
L
SCNX: Rapid revenue growth and FDA-approved launches highlight a strong specialty pharma pipeline
Focused on innovative specialty pharmaceuticals, the company has launched FDA-approved Arbli™ and Rezenopy®, with a robust pipeline targeting CNS, cardiovascular, and pain markets. Strong IP, experienced leadership, and
REGULATION | Sep 14, 2026, 08:02 PM UTC
H
HITI - High Tide Reports Record-Breaking Third Quarter 2026 Financial Results
HITI - High Tide Reports Record-Breaking Third Quarter 2026 Financial Results
EARNINGS | Sep 14, 2026, 08:02 PM UTC
L
FORM 4P - ECVT - Ecovyst Inc. DIRECTOR: Humble Patti A. P | 24,875 | $10.05 | $249,994
FORM 4P - ECVT - Ecovyst Inc. DIRECTOR: Humble Patti A. P | 24,875 | $10.05 | $249,994
NEWS | Sep 14, 2026, 08:02 PM UTC
L
IGT Appoints Adam Chibib as Chief Financial Officer
IGT appointed Adam Chibib as CFO, effective Nov. 1, 2026, subject to required regulatory approvals. Fabio Celadon remains CFO through Oct. 31 and will advise through Dec. 31, 2026.Material DetailsContext by AI AnalystThi
NEWS | Sep 14, 2026, 08:02 PM UTC
H
ZELENSKYY: WANT US TO ENSURE RUSSIA 'READY TO STOP THIS WAR'
ZELENSKYY: WANT US TO ENSURE RUSSIA 'READY TO STOP THIS WAR'
GEOPOLITICS | Sep 14, 2026, 08:01 PM UTC
H
INSM: BRINSUPRI's blockbuster launch and robust pipeline set the stage for sustained, multi-year growth
BRINSUPRI's launch has exceeded expectations, with first-year revenue estimates of $1.25—$1.4 billion and peak sales guidance raised above $7 billion. Expansion into COPD/asthma comorbid populations and international mar
EARNINGS | Sep 14, 2026, 08:01 PM UTC
L
General Motors Is Maintained at Buy by UBS
Ratings actions from Benzinga: GMT) General Motors Price Target Raised to $114.00/Share From $102.00 by UBSRatings actions from Benzinga
NEWS | Sep 14, 2026, 08:01 PM UTC
L
Amylyx Pharmaceuticals Insiders Sold Shares Worth Over $1.9M
Justin B. Klee, a director and Co-Chief Executive Officer, sold common stock in automatic transactions to cover tax withholding on vested performance stock units at weighted average sale prices of $32.1293 for one block
EQUITY | Sep 14, 2026, 08:01 PM UTC
H
Kestra Medical Techs Raises FY2027 Sales Guidance from $137.000M to $141.000M vs $137.023M Est
Kestra Medical Techs (NASDAQ: KMTS ) raises FY2027 sales outlook from $137.000 million to $141.000 million vs $137.023 million estimate.
LIVE | Sep 14, 2026, 08:01 PM UTC
L
High Tide Inc. (TSXV:HITI) Posts Record Q3 Revenue and Profit
High Tide reported record Q3 FY2026 results, citing record revenue, gross profit, Adjusted EBITDA, income from operations, net income and operating cash flow before working capital, and said its EBITDA margin is at a 12-
EARNINGS | Sep 14, 2026, 08:01 PM UTC
L
Kestra Medical Techs 1Q Rev $31M >KMTS
Kestra Medical Techs 1Q Rev $31M >KMTS
NEWS | Sep 14, 2026, 08:01 PM UTC
L
Kestra Medical Techs 1Q Loss/Shr 75c >KMTS
Kestra Medical Techs 1Q Loss/Shr 75c >KMTS
NEWS | Sep 14, 2026, 08:01 PM UTC
L
High Tide Inc. (TSXV:HITI) Reports Record Q3 Revenue, EBITDA and Net Income
High Tide Inc. reported record Q3 FY2026 results, citing record revenue, gross profit, Adjusted EBITDA, income from operations, net income, and operating cash flow before working capital.Material DetailsContext by AI Ana
EARNINGS | Sep 14, 2026, 08:01 PM UTC
L
Benitec Biopharma FY26 Loss $45.5M >BNTC
Benitec Biopharma FY26 Loss $45.5M >BNTC
EQUITY | Sep 14, 2026, 08:01 PM UTC
L
Law firm Morgan & Morgan touts $1 billion AI investment, plans to sell platform to other firms
By Sara MerkenMorgan & Morgan, which bills itself as the largest U.S. personal injury law firm, said on Monday that it has committed to investing at least $1 billion into AI and technology over the next decade and will b
NEWS | Sep 14, 2026, 08:01 PM UTC
L
BIVI - BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
BIVI - BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
NEWS | Sep 14, 2026, 08:01 PM UTC
L
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that on September 10, 2026, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non
EQUITY | Sep 14, 2026, 08:01 PM UTC
L
BDSX - Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
BDSX - Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
NEWS | Sep 14, 2026, 08:01 PM UTC
L
BRIEF-High Tide Q3 Revenue CAD 198.818 Million Vs. IBES Estimate CAD 189.8 Million
Sep 14 (Reuters) - High Tide Q3 basic EPS CAD 0.13.
EARNINGS | Sep 14, 2026, 08:01 PM UTC
L
BRIEF-High Tide Q3 Income From Operations CAD 8.71 Million
Sep 14 (Reuters) - High Tide Q3 gross profit CAD 52.746 million.
EARNINGS | Sep 14, 2026, 08:01 PM UTC
L
KMTS - Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
KMTS - Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
EARNINGS | Sep 14, 2026, 08:01 PM UTC
L
Crop Progress: U.S. Cotton 34% Vp-pr, 30 Fair, 36 Gd-ex
Crop Progress: U.S. Cotton 34% Vp-pr, 30 Fair, 36 Gd-ex
NEWS | Sep 14, 2026, 08:01 PM UTC
L
SION - Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial
SION - Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial
NEWS | Sep 14, 2026, 08:01 PM UTC
L
Crop Progress: U.S. Spg Wheat 93% Harvested; 93 Yr Ago, 92 Avg
Crop Progress: U.S. Spg Wheat 93% Harvested; 93 Yr Ago, 92 Avg
NEWS | Sep 14, 2026, 08:01 PM UTC
L
Crop Progress: U.S. Sybns 44% Dropping Leaves; 38 Yr Ago, 37 Avg
Crop Progress: U.S. Sybns 44% Dropping Leaves; 38 Yr Ago, 37 Avg
NEWS | Sep 14, 2026, 08:01 PM UTC
L
Crop Progress: U.S. Sybns 13% Vp-pr, 29 Fair, 58 Gd-ex
Crop Progress: U.S. Sybns 13% Vp-pr, 29 Fair, 58 Gd-ex
NEWS | Sep 14, 2026, 08:01 PM UTC
L
Crop Progress: U.S. Winter Wheat 8% Planted; 10 Yr Ago, 12 Avg
Crop Progress: U.S. Winter Wheat 8% Planted; 10 Yr Ago, 12 Avg
NEWS | Sep 14, 2026, 08:00 PM UTC